Drug
Anastrozole clinical trials
Also written Arimidex, ZD1033 and ICI-D1033.
- studies test it
- 149
- open now
- 15
- in phase 3
- 40
- first study started
- 1996
Keep track of what changes. Save the Anastrozole studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
149 studies that test it; most in 2004 (12)
| Year | Studies |
|---|---|
| 1996 | 4 |
| 1997 | 1 |
| 1998 | 4 |
| 1999 | 1 |
| 2000 | 2 |
| 2001 | 4 |
| 2002 | 2 |
| 2003 | 6 |
| 2004 | 12 |
| 2005 | 11 |
| 2006 | 9 |
| 2007 | 10 |
| 2008 | 7 |
| 2009 | 4 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 8 |
| 2015 | 4 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 6 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 2
- Phase 1
- 21
- Phase 2
- 64
- Phase 3
- 40
- Phase 4
- 13
- No phase
- 14
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 45 · Other 104
AstraZeneca (27) · Massachusetts General Hospital (4) · National Cancer Institute (NCI) (4) · Washington University School of Medicine (3) · Alliance for Clinical Trials in Oncology (2) · Eli Lilly and Company (2) · Baylor College of Medicine (2) · Institut Claudius Regaud (2)
Often tested with
Tested in the same studies.
Tamoxifen (27) · Letrozole (24) · Fulvestrant (23) · Exemestane (19) · Testosterone (10) · Goserelin (7) · Palbociclib (6) · Abemaciclib (6)
Studies
Open first, then newest update. How each study uses Anastrozole is read from its arms, and is right about nine times in ten.
Testing it · 149
- Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA StudyEnrolling by invitationPhase 3Tolmar Inc.NCT05645536Written as Anastrozole Tablets
- Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast CancerRecruitingPhase 2University of California, IrvineNCT05524584Written as Anastrozole
- Reversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Inguinal Hernias in MalesRecruitingPhase 1Northwestern UniversityNCT07604272Written as Anastrozole (ARIMIDEX™)
- DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as TreatmentRecruitingPhase 2QuantumLeap Healthcare CollaborativeNCT06075953Written as Anastrazole
- A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceRecruitingPhase 3Stemline Therapeutics, Inc.NCT06492616Written as Anastrozole
- Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast CancerRecruitingPhase 3AstraZenecaNCT06380751Written as Anastrozole
- ETHAN - ET for Male BCRecruitingPhase 2Jose Pablo LeoneNCT05501704Written as Anastrozole
- Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence ScoreRecruitingPhase 2Washington University School of MedicineNCT02476786Written as Anastrozole
- Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter SyndromeRecruitingPhase 3Georgios PapadakisNCT05586802Written as Anastrozole
- Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite AthletesEnrolling by invitationNot applicableEnhanced Emirates LimitedNCT07568574Written as Anastrozole
- NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast CancerRecruitingPhase 2Washington University School of MedicineNCT05837455Written as Anastrozole
- Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast CancerRecruitingPhase 2Jonsson Comprehensive Cancer CenterNCT04553770Written as Anastrozole
- A Trial to Evaluate Sacituzumab Govitecan in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Metastatic Breast Cancer Progressed on CDK4/6 InhibitorsNot yet recruitingPhase 1Hunan Cancer HospitalNCT07163481Written as Sacituzumab Govitecan + Anastrozole / Exemestane
- Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast CancerNot yet recruitingPhase 3Region Örebro CountyNCT06223698Written as Anastrozole
- Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in SituRecruitingPhase 2Institut Cancerologie de l'OuestNCT04666961Written as Anastrozole 1Mg Tab
- Aromatase Inhibitors and Weight Loss in Severely Obese Men With HypogonadismCompletedPhase 4Baylor College of MedicineNCT03490513Written as anastrozole (1 mg/day)
- PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast CancerActive, not recruitingPhase 2Washington University School of MedicineNCT01723774Written as Anastrozole
- ER Reactivation Therapy for Breast CancerCompletedPhase 2Dartmouth-Hitchcock Medical CenterNCT02188745Written as Anastrozole
- Brain Blood Flow Responses to Stress: Sex DifferencesCompletedPhase 4University of Wisconsin, MadisonNCT06253702Written as Anastrozole
- Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast CancerCompletedPhase 2Irada Ibrahim-zadaNCT05150652Written as Anastrozole 1mg
See all 149 studies that test Anastrozole →
Given in every arm · 78 — Anastrozole is usual care beside what is tested
- Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low TrialRecruitingPhase 3National Cancer Institute (NCI)NCT07391774Written as Anastrozole
- A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)RecruitingPhase 3Eli Lilly and CompanyNCT07174336Written as Anastrozole
- Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast CancerRecruitingPhase 2University of WashingtonNCT06179303Written as Anastrozole
- Study of 18F-FFNP Breast PET/MRIRecruitingPhase 2University of Wisconsin, MadisonNCT06086704Written as Anastrozole
- Fulvestaciclib Combined With Anti-HER2 and Endocrine Therapy for HR+/HER2+ Advanced Breast CancerNot yet recruitingPhase 2Fudan UniversityNCT07716046Written as Anastrozole
- Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial CancerRecruitingPhase 2Jonsson Comprehensive Cancer CenterNCT04469764Written as Anastrozole
- Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast CancerRecruitingPhase 2Oana DanciuNCT05467891Written as Anastrozole
- First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid TumorsRecruitingPhase 1/2Eli Lilly and CompanyNCT05768139Written as Anastrozole
- Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine TherapyRecruitingPhase 2Yale UniversityNCT06953882Written as Anastrazole 1mg
- Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical StudyRecruitingPhase 2Fujian Cancer HospitalNCT07581834Written as Endocrine Therapy (ET): letrozole, anastrozole, exemestane, tamoxifen
- The Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in HumansNot yet recruitingNot applicableUniversity of British ColumbiaNCT07212712Written as Anastrozole (Arimidex)
- Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)RecruitingPhase 3Fudan UniversityNCT05891093Written as Anastrozole
- S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerActive, not recruitingPhase 3SWOG Cancer Research NetworkNCT01674140Written as anastrozole
- Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast CancerActive, not recruitingPhase 3Tolmar Inc.NCT04906395Written as Anastrozole Tablets
- Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast CancerActive, not recruitingPhase 3Alliance Foundation Trials, LLC.NCT02947685Written as Anastrozole
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast CancerActive, not recruitingPhase 3National Cancer Institute (NCI)NCT01272037Written as Anastrozole
- Roll-over Study to Allow Continued Access to RibociclibActive, not recruitingPhase 4Novartis PharmaceuticalsNCT05161195Written as Anastrozole
- TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast CancerCompletedPhase 2Mayo ClinicNCT03179904Written as Anastrozole
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)Active, not recruitingPhase 3National Cancer Institute (NCI)NCT00310180Written as Anastrozole
- A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast CancerActive, not recruitingPhase 1AstraZenecaNCT04556773Written as Anastrozole
Showing 20 of 78.
As the comparator · 27 — what is tested is compared with Anastrozole
- A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine TherapyRecruitingPhase 3AstraZenecaNCT05774951Written as Anastrozole
- A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian CancerRecruitingPhase 3Verastem, Inc.NCT06072781Written as Anastrozole
- Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)RecruitingPhase 3European Organisation for Research and Treatment of Cancer - EORTCNCT05512364Written as Anastrozole 1mg
- A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast CancerRecruitingPhase 3Shandong Suncadia Medicine Co., Ltd.NCT07024173Written as Anastrozole Tablets
- Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After LumpectomyRecruitingPhase 2UNC Lineberger Comprehensive Cancer CenterNCT05472792Written as tamoxifen, anastrozole, exemestane, letrozole, fulvestrant, toremifene
- A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast CancerRecruitingPhase 3Shandong Suncadia Medicine Co., Ltd.NCT07349069Written as Anastrozole Tablets
- Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)RecruitingPhase 3Japanese Foundation for Cancer ResearchNCT07190443Written as Endocrine Therapy (ET): letrozole, anastrozole, exemestane, tamoxifen
- A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast CancerRecruitingPhase 2Royal Marsden NHS Foundation TrustNCT04985266Written as Anastrozole
- A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced DiseaseActive, not recruitingPhase 3AstraZenecaNCT04711252Written as Anastrozole
- Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)Active, not recruitingPhase 3AstraZenecaNCT04964934Written as Anastrozole
- Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam TrialSuspendedPhase 3Alliance for Clinical Trials in OncologyNCT06671912Written as Anastrozole
- OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerActive, not recruitingPhase 3Olema Pharmaceuticals, Inc.NCT06016738Written as Anastrozole
- An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)Active, not recruitingPhase 3AstraZenecaNCT05952557Written as Anastrozole
- A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast CancerActive, not recruitingPhase 3Eli Lilly and CompanyNCT05514054Written as Anastrozole
- A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.CompletedPhase 3AstraZenecaNCT01602380Written as arimidex 1mg
- A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast CancerCompletedPhase 2ETOP IBCSG Partners FoundationNCT05896566Written as Anastrozole
- Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast CancerTerminatedPhase 2SanofiNCT04059484Written as Anastrozole
- ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast CancerActive, not recruitingPhase 3Azienda Ospedaliero-Universitaria CareggiNCT04134598Written as Endocrine Therapy (ET): letrozole, anastrozole, exemestane, tamoxifen
- A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to SurgeryCompletedPhase 2Arvinas Inc.NCT05549505Written as Anastrozole
- Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT StudyTerminatedPhase 2M.D. Anderson Cancer CenterNCT04256941Written as Anastrozole
Showing 20 of 27.
Codes
What other systems call Anastrozole · ClinicalTrials.gg INT006710
- MeSH (NLM) D000077384AnastrozoleConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 2Z07MYW1AZANASTROZOLEConfirmed FDA, NLM, Wikidata
- RxNorm 84857Confirmed FDA, Wikidata
- Wikidata Q419143anastrozoleConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1607AnastrozoleOne source FDA
- DrugBank DB01217One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077384 | Anastrozole | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 2Z07MYW1AZ | ANASTROZOLE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 84857 | — | Confirmed FDA, Wikidata |
| Wikidata | Q419143 | anastrozole | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1607 | Anastrozole | One source FDA |
| DrugBank | DB01217 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.